Debra L. Rateri

T lymphocytes in atherosclerosis: the yin-yang of Th1 and Th2 influence on lesion formation.

Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology.

Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice.

IL-5 links adaptive and natural immunity in reducing atherosclerotic disease.

Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.

Development of experimental designs for atherosclerosis studies in mice.

Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis.

Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice.

Atherosclerosis: cell biology and lipoproteins.

Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography.

Atherosclerosis: cell biology and lipoproteins.

Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.

Role of the renin-angiotensin system in the development of abdominal aortic aneurysms in animals and humans.

Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

Immunostaining of mouse atherosclerotic lesions.

Atherosclerosis: cell biology and lipoproteins.

The role of the renin-angiotensin system in aortic aneurysmal diseases.

As macrophages indulge, atherosclerotic lesions bulge.

ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.

Atherosclerosis: cell biology and lipoproteins.

Modes of defining atherosclerosis in mouse models: relative merits and evolving standards.

Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.

S100A12 links to thoracic aortic aneurysms.

Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.

Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.

Impact of serum amyloid A on high density lipoprotein composition and levels.

Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice.

Membrane cholesterol modulates the fluid shear stress response of polymorphonuclear leukocytes via its effects on membrane fluidity.

Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm.

MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.

Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.

Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms.

Protein Kinase C-Delta Mediates Adventitial Cell Migration Through Regulation of Monocyte Chemoattractant Protein-1 Expression in a Rat Angioplasty Model.

Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms.

Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms.

Novel mechanisms of abdominal aortic aneurysms.

Citrullus lanatus 'sentinel' (watermelon) extract reduces atherosclerosis in LDL receptor-deficient mice.

Do vivarium conditions influence atherosclerotic lesion size?

Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice.

Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.

Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice.

Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms.

PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism.

Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice.

Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.

Aortic aneurysms in Loeys-Dietz syndrome - a tale of two pathways?

Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms.

Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies.

Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.

Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II-Induced Medial Hyperplasia in the Ascending Aorta.

Abdominal aortic aneurysm: novel mechanisms and therapies.